drugset / Trial / NCT01525147

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers

NCT01525147 ↗

Phase 1 Completed 49 enrolled Yuhan Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A block-randomized, double-blind, placebo-controlled, single-dose escalating, phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of YHB1411-2 in healthy male volunteers

Timeline

Start
2011-12
Primary completion
2013-06
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject YHB1411-2 Unknown — Intravenous

Indications